摘要
心脏再同步化治疗(CRT)是慢性心力衰竭器械治疗中的一种方法,通过左右心室同时起搏纠正心室收缩的不同步,从而逆转心室重构,提高射血分数,改善临床预后。自20世纪90年代开始CRT应用于临床,现已得到广泛应用,但其也存在植入难度大、易脱位、费用高等诸多缺点,难以在基层推广。希浦氏起搏是近年来开展的新的心脏起搏技术,有研究表明,希浦氏起搏可以获得传统CRT类似甚至更好的临床效果,为慢性心力衰竭的起搏治疗带来了新的希望。该文就CRT的研究现状与希浦氏起搏在慢性心力衰竭中应用前景进行综述。
Cardiac resynchronization therapy(CRT)is a kind of device therapy for chronic heart failure.It can correct ventricular systolic asynchrony,reverse ventricular remodeling,increase ejection fraction and improve clinical prognosis by pacing left and right ventricles simultaneously.Since the 1990s,CRT has been applied in clinic and has been widely used.However,it is difficult to popularize in primary hospitals due to its disadvantages such as difficult implantation,easy dislocation and high cost.His-Purkinje system pacing is a new cardiac pacing technique developed in recent years.Studies have showed that the clinical effect of His-Purkinje system pacing is similar to or even better than that of conventional CRT,bringing new hope for the pacing treatment of chronic heart failure.This paper reviews the research status of CRT and the application prospect of His-Purkinje system pacing in chronic heart failure.
作者
陆政德
石磊
胡昌兴
LU Zheng-de;SHI Lei;HU Chang-xing(Department of Cardiology,the People′s Hospital of Guangxi Zhuang Autonomous Region,Nanning 530021,China)
出处
《中国临床新医学》
2021年第6期559-564,共6页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金
广西科技计划项目(编号:桂科AD17129026)。
关键词
心脏再同步化治疗
希浦氏起搏
慢性心力衰竭
Cardiac resynchronization therapy(CRT)
His-Purkinje system pacing
Chronic heart failure
